|May 9, 2012|
First funds offered from new science and technology development program
|Congressman Chakah Fattah|
“A lot has been said here, but I just have to point rather than curse the darkness I want to light the candle. We have this big deal going on between the American Heart Association and Penn to get at many of these issues. And I want just want to recognize and thank you for what you are doing; and this is a big deal for our region and hopefully is a forerunner of much more.”
|Richard Bendis, CEO of Biohealth Innovations|
“Key is, also, if you want to sustain an (health) ecosystem you have to find a way government, academia, industry, and a more emerging important role is nonprofit foundations and NGOs. We have someone here from the Heart Association, right now in the front row. Basically what I am finding is that disease foundations are starting to recognize their role in the development and cures of drugs and understand the role necessary to interact with the private sector at a much earlier stage. But most people don’t know how to interact with them. And as the key is, this is another element, these NGOs and foundations are people we need to get involved in the process of building these innovation ecosystems and they can accelerator translation of commercial research.”
|Sep. 19, 2012|
Money Matters 12-26 featuring Jonni Moore, PhD from CytoVas
High Dimensional Flow Cytometry Comes of Age
European Pharmaceutical Review (2012) Volume 17, Issue 4
|Oct. 5, 2012|
CytoVas advancing vascular test, with AHA funding aid
Philadelphia Business Journal by John George, Senior Reporter
Cytomics: Managing Biocomplexity in Drug Development, Clinical Diagnostics, and Clinical Medicine, by Pascal Yvon and Rick Turner
Special thanks to International Pharmaceutical Media for permission to publish.
Visit the IPM web site.